Common use of GSK Report Clause in Contracts

GSK Report. Within forty-five (45) days after the end of each ---------- Calendar Quarter, on a Collaboration Product-by-Collaboration Product basis in the United States, GSK shall submit to Adolor a written report (each, a "GSK --- Report") setting forth in reasonable detail the following items during such ------ Calendar Quarter: (a) Development Expenses incurred by GSK for each: (i) Adolor Product; and (ii) GI Product for which Adolor will receive a percentage of GI Product Marketing Contribution; (b) Marketing Expenses incurred by GSK for each: (i) Adolor Product; and (ii) the OBD Chronic Product and each other GI Product for where Adolor has elected to fund Development Expenses under Section 4.6.5, and where Adolor has not made a Royalty Conversion Election;